We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

BRAF L525R - Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene BRAF
Variant L525R
Impact List missense
Protein Effect gain of function - predicted
Gene Variant Descriptions BRAF L525R lies within the protein kinase domain of the Braf protein (UniProt.org). L525R results in increased activation of Erk signaling in a dimer-dependent but RAS-independent manner (PMID: 31515458, PMID: 28972961), and therefore, is predicted to lead to a gain of Braf protein function.
Associated Drug Resistance
Category Variants Paths

BRAF mutant BRAF act mut BRAF L525R

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_004333.6
gDNA chr7:g.140777032A>C
cDNA c.1574T>G
Protein p.L525R
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
NM_001378474.1 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001378473.1 chr7:g.140754198A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
XM_047420767.1 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
XM_017012559.1 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
XM_047420768.1 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
XM_017012558.1 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
NM_004333.6 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001374258.1 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
NM_004333.5 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001354609.2 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001354609.1 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001374244.1 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
XM_047420769.1 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001378472.1 chr7:g.140754198A>C c.1574T>G p.L525R RefSeq GRCh38/hg38
NM_001378475.1 chr7:g.140753297_140753298delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
XM_017012559.2 chr7:g.140778054_140778055delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
XM_047420766.1 chr7:g.140776996_140776997delTTinsAG c.1573_1574delTTinsAG p.L525R RefSeq GRCh38/hg38
NM_001378468.1 chr7:g.140777032A>C c.1574T>G p.L525R RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
BRAF L525R colorectal cancer not predictive Cetuximab Case Reports/Case Series Actionable In a clinical study, Erbitux (cetuximab) treatment as a third-line therapy resulted in stable disease with progression-free survival of 4 months in a patient with metastatic colorectal cancer harboring BRAF L525R (PMID: 31515458). 31515458
BRAF L525R Advanced Solid Tumor sensitive Selumetinib Preclinical - Cell culture Actionable In a preclinical study, Koselugo (selumetinib) inhibited viability of cells expressing BRAF L525R in culture (PMID: 36856908). 36856908
BRAF L525R Advanced Solid Tumor predicted - sensitive Dactolisib + Selumetinib Preclinical - Cell culture Actionable In a preclinical study, the addition of Dactolisib (BEZ235) to treatment with Koselugo (selumetinib) resulted in increased inhibition of proliferation in Koselugo (selumetinib)-resistant cells expressing BRAF L525R compared to Dactolisib (BEZ235) alone (PMID: 36856908). 36856908
BRAF L525R Advanced Solid Tumor sensitive Dactolisib Preclinical - Cell culture Actionable In a preclinical study, Dactolisib (BEZ235) inhibited viability of cells expressing BRAF L525R in culture (PMID: 36856908). 36856908